Related Experiment Video
Updated: May 22, 2026

Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells
Published on: April 28, 2026
Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase
H Hiyoshi1, S Abdelhady, L Segerström
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm SE-17177, Sweden.
Background:
Cellular quiescence is a state of reversible proliferation arrest that is induced by anti-mitogenic signals. The endogenous cardiac glycoside ouabain is a specific ligand of the ubiquitous sodium pump, Na,K-ATPase, also known to regulate cell growth through unknown signalling pathways.
Methods:
To investigate the role of ouabain/Na,K-ATPase in uncontrolled neuroblastoma growth we used xenografts, flow cytometry, immunostaining, comet assay, real-time PCR, and electrophysiology after various treatment strategies.
Results:
The ouabain/Na,K-ATPase complex induced quiescence in malignant neuroblastoma. Tumour growth was reduced by >50% when neuroblastoma cells were xenografted into immune-deficient mice that were fed with ouabain. Ouabain-induced S-G2 phase arrest, activated the DNA-damage response (DDR) pathway marker γH2AX, increased the cell cycle regulator p21(Waf1/Cip1) and upregulated the quiescence-specific transcription factor hairy and enhancer of split1 (HES1), causing neuroblastoma cells to ultimately enter G0. Cells re-entered the cell cycle and resumed proliferation, without showing DNA damage, when ouabain was removed.
Conclusion:
These findings demonstrate a novel action of ouabain/Na,K-ATPase as a regulator of quiescence in neuroblastoma, suggesting that ouabain can be used in chemotherapies to suppress tumour growth and/or arrest cells to increase the therapeutic index in combination therapies.
Insights
Ouabain, a cardiac glycoside, induces reversible cell cycle arrest in neuroblastoma by targeting the Na,K-ATPase. This discovery suggests ouabain as a potential therapy to suppress tumor growth and enhance combination treatments.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Cellular quiescence is a reversible state of proliferation arrest.
- Ouabain, an endogenous cardiac glycoside, binds to Na,K-ATPase and influences cell growth via signaling pathways.
Purpose of the Study:
- Investigate the role of ouabain/Na,K-ATPase in neuroblastoma growth.
- Determine ouabain's potential as a therapeutic agent.
Main Methods:
- Utilized xenografts, flow cytometry, immunostaining, comet assay, real-time PCR, and electrophysiology.
- Administered ouabain treatments to neuroblastoma models.
Main Results:
- Ouabain/Na,K-ATPase complex induced quiescence in malignant neuroblastoma.
- Tumor growth reduced by over 50% in ouabain-fed mice.
- Ouabain triggered S-G2 phase arrest, activated DNA-damage response (γH2AX), increased p21(Waf1/Cip1), and upregulated HES1, leading to G0 arrest. Cells resumed proliferation without DNA damage upon ouabain removal.
Conclusions:
- Ouabain/Na,K-ATPase is a novel regulator of quiescence in neuroblastoma.
- Ouabain shows potential for chemotherapy to suppress tumor growth.
- Ouabain can arrest cells, potentially increasing the therapeutic index in combination therapies.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Amplifying Signals via Enzymatic Cascade
The Intrinsic Apoptotic Pathway
The Ras Gene
Ras is a superfamily...
Regulation of Nuclear Protein Sorting
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
